Pedi Anthrax Trial: Experts Shade their Derrieres
UPDATE: I sent this article to the Commission’s Communications Director, and asked her to point out any errors in the article, which I would be delighted to fix, were any to be found.
From the LATimes: In a poll of 1,678 U.S. parents conducted by the University of Michigan’s C.S. Mott Children’s Hospital, 40% said they would get their children immunized against the H1N1 virus — even as 54% indicated they would get their kids vaccinated against regular seasonal flu.
UPDATE: From the October 18 MailOnline: Ambulance chiefs face renewed pressure to explain the loss of a key medical record relating to the death of Dr David Kelly after the investigating police force said it had no record of ever having received the document. Bosses at South Central Ambulance NHS Trust were criticised last month…
And here is the URL for the leaked slide deck–it was hard to find. https://context-cdn.washingtonpost.com/notes/prod/default/documents/54f57708-a529-4a33-9a44-b66d719070d9/note/753667d6-8c61-495f-b669-5308f2827155.#page=1 These are CDC’s slides. They don’t always tell the truth. Occasionally they do. And here is an article giving you other interesting numbers from the CDC’s Provincetown data, which were released after the leak: CDC study shows 74% of people…
Freedom of Speech must never again be shuttered, trampled on or blasphemied as the crime of “Misinformation, Disinformation or Malinformation” Judge Doughty used 721 footnotes. He must have amazing young clerks. And on page 3 the good Judge included the following quotes to remind us why July 4 and our nation’s principles are so important…
Here’s the Report, written by the Transfusion Transmitted Disease Committee of the American Association of Blood Banks. Notable quotes: Physicochemical properties: Stable at room temperature and can resist desiccation (drying); inactivated at 60°C [140 F] for 30 minutes [However, the 1984 Mitchell and McCormick paper that studied virus inactivation found that the time to inactivation…
https://www.forbes.com/sites/alexknapp/2020/03/13/coronavirus-drug-update-the-latest-info-on-pharmaceutical-treatments-and-vaccines/#49181a7e21db Expect to see ASO3 or related adjuvant from GSK in experimental Coronavirus vaccines: GSK has previously developed a pandemic vaccine adjuvant platform, a system that helps to improve vaccines by strengthening the immune response in patients who receive it. In February, the company announced it was partnering with the Coalition for Epidemic Preparedness Innovations to use that platform…